Copper prescription in pregnancy

Phase 3

• Conditions: Pregnancy, childbirth and the puerperium; O00-O99; pregnancy outcome.

• Registration Number: IRCT201008112624N7
• Lead Sponsor: Deputy of Research and Technology, Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

nuliparity, age between 18-35, second trimester of pregnancy, and having written consent. Exclusion criteria: multiple pregnancy, history of any systemic disorders or drug use except iron supplement, known copper sensitivity, polyhydramnios, fetal death, fetal anomalies, smoking, alcohol consumption and drug abuse.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Preterm premature rupture of membranes and premature rupture of membranes. Timepoint: 9 months. Method of measurement: questionnaire.

Secondary Outcome Measures

Name	Time	Method
Pregnancy outcome. Timepoint: 9 months. Method of measurement: questionnaire.;Birth weight. Timepoint: Delivery. Method of measurement: questionnaire.;Placental abruption, placenta previa, hemorrhage during pregnancy. Timepoint: 9 months. Method of measurement: questionnaire.;Anemia. Timepoint: 9 months. Method of measurement: Hemoglobin.;Preterm labor. Timepoint: 9 months. Method of measurement: questionnaire.;Preeclampsia. Timepoint: 9 months. Method of measurement: questionnaire.;Drug adverse effects. Timepoint: 9 months. Method of measurement: questionnaire.;Infection. Timepoint: 9 months. Method of measurement: questionnaire.